Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
LUCID DIAGNOSTICS INC.
luciddiagnostics.comAI Executive Summary
AI-powered analysis of 8-K filing content
Lucid Diagnostics Inc. entered into an underwriting agreement with Canaccord Genuity LLC and BTIG, LLC on April 23, 2026, to conduct an underwritten public offering of common stock at $1.00 per share. This capital raise is significant for funding future operations and will impact the company's capital structure.
Key Takeaways
Company is raising capital through an underwritten public offering at $1.00 per share
Canaccord Genuity LLC and BTIG, LLC are serving as underwriters for the offering
2 more takeaways